-
Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides KH.
Ultrasound Obstet Gynecol 2017;50:45-48. pdf -
Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size.
Papacleovoulou G, Nikolova V, Oduwole O, Chambers J, Vazquez-Lopez M, Jansen E, Nicolaides K, Parker M, Williamson C.
FASEB J 2017;31:1698-1708. pdf -
Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation.
Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;11:391-400. -
Screening for fetal abnormalities in multiple pregnancies.
Sebire NJ, Nicolaides KH.
Baillieres Clin Obstet Gynaecol 1998;12:19-36. -
Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation.
Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH.
J Med Genet 1998;35:222-4.